(Q74815870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Tanja Fehm

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Gerhard Gebauer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Wolfram Jäger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

97-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243512%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1019601022456

13 November 2019

exact match

0 references

cites work

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

C-erbB-2 protein in the sera of breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

ElevatederbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Serum c-erbB-2 in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Serial serum c-erbB-2 levels in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Detection of C-ERBB-2 Related Protein in Sera from Breast Cancer Patients Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601022456

7 January 2021